Drug Type Small molecule drug |
Synonyms (E)-3-(4-hydroxyx-3-methoxystyryl)-5-methoxy-4-(3-methylbut-2-en-1-yl)phenol |
Target |
Action modulators, inhibitors |
Mechanism TUB modulators(TUB bipartite transcription factor modulators), Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain metastases | Preclinical | Australia | 01 Feb 2025 | |
Glioblastoma | Preclinical | Australia | 01 Feb 2025 | |
Pancreatic Cancer | Preclinical | Australia | 01 Feb 2025 |